Can-Fite Biopharma Ltd - ADR

ASE:CANF   4:00:00 PM EDT
+0.01 (+0.40%)
0:00:00 AM EDT: $2.65 +0.14 (+5.58%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)10.25M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$0.2 Million
Adjusted EPS-$0.61
See more estimates
10-Day MA$2.58
50-Day MA$2.76
200-Day MA$3.17
See more pivots

Can-Fite Biopharma Ltd - ADR Stock, ASE:CANF

10 Bareket Street, Kiryat Matalon, Petach Tikva, HaMerkaz 49170
Phone: +972.3.924.1114
Number of Employees:


Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. Its product pipeline include Piclidenoson, Namodenoson, and CF602. The company was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach-Tikva, Israel.